Will platelets drop after stopping eltrombopag?

Eltrombopag is a small molecule, non-peptide TPO receptor agonist, which can promote the production of platelets and is mainly used to treat thrombocytopenia that is difficult to treat with immunoglobulins and glucocorticoids.

Platelets may remain elevated for a period of time after stopping the drug due to the long-lasting effects of eltrombopag. However, over time, the effect of the drug wears off and the platelet count may gradually return to the level before taking the drug. Some patients may experience a continued decrease in platelet count after stopping the drug. This may be related to individual patient differences, severity of disease, and other potential factors.

The patient's physical condition and the severity of the disease will affect platelet changes after drug withdrawal. For example, if a patient's thrombocytopenia is caused by an autoimmune disease or other chronic condition, platelets may be more likely to fall after discontinuation of the drug. The drug dose and treatment duration before discontinuation also affect platelet changes. If patients have been taking high doses of eltrombopag for a long time before discontinuing the drug, the risk of platelet decline after discontinuation may be increased.

To reduce the risk of platelet decline after discontinuation of medication, doctors often develop a personalized discontinuation strategy based on the patient's specific circumstances. This may include gradually reducing the drug dose, extending the dosing interval, or using other adjunctive medications to maintain platelet counts.

Patients should closely monitor platelet counts after discontinuation of the drug so that any abnormalities can be detected and addressed promptly. If platelets continue to drop, you should seek medical advice promptly and seek medical advice.